Inpatient versus outpatient initiation of antiarrhythmic drug therapy for patients with supraventricular tachycardia. [electronic resource]
- Clinical cardiology Sep 1994
- II7-10 p. digital
Publication Type: Journal Article; Review
0160-9289
10.1002/clc.4960171405 doi
Ambulatory Care Anti-Arrhythmia Agents--adverse effects Cardiomyopathies--complications Flecainide--adverse effects Hospitalization Humans Propafenone--adverse effects Risk Tachycardia, Supraventricular--chemically induced Time Factors